M. A. Boronat

Chronic morphine induces up‐regulation of the pro‐apoptotic Fas receptor and down‐regulation of the anti‐apoptotic Bcl‐2 oncoprotein in rat brain

J. García-Sevilla, M. García-Fuster, M. A. Boronat, 2001, British journal of pharmacology.

Activation of I2‐imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors

G. Olmos, J. García-Sevilla, P. Sánchez-Blázquez, 2000, British journal of pharmacology.

Pharmacologic and Molecular Discrimination of I2‐Imidazoline Receptor Subtypes a

G. Olmos, J. García-Sevilla, M. A. Boronat, 1999, Annals of the New York Academy of Sciences.

Protection by imidazol(ine) drugs and agmatine of glutamate‐induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor

G. Olmos, N. DeGregorio-Rocasolano, T. Gasull, 1999, British journal of pharmacology.

Attenuation of tolerance to opioid‐induced antinociception and protection against morphine‐induced decrease of neurofilament proteins by idazoxan and other I2‐imidazoline ligands

G. Olmos, J. García-Sevilla, M. A. Boronat, 1998, British journal of pharmacology.

Isothiocyanatobenzyl imidazoline is an alkylating agent for I2-imidazoline binding sites in rat and rabbit tissues

Duane D. Miller, G. Olmos, J. García-Sevilla, 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

Attenuation of Tolerance to Opioid‐Induced Antinociception by Idazoxan and Other I2‐Ligands a

G. Olmos, J. García-Sevilla, M. A. Boronat, 1999, Annals of the New York Academy of Sciences.